SenzaGen AB operates within the Commercial physical research sector.
In addition to historical fundamental analyses, the complete report available to purchase compares SenzaGen AB with three other
companies in this sector in SWEDEN :
sales of 2.49 million Swedish Kronor [US$287,040.56 ]
Biovica International AB
(3.01 million Swedish Kronor [US$346,686.85 ]
(2.66 million Swedish Kronor [US$306,653.46 ]
of which 100%
was Research, development & License).
During the year ended December of 2019, sales at
SenzaGen AB were SEK 2.72 million (US$314.27 thousand).
increase of 36.4%
versus 2018, when the company's sales were SEK 2.00 million.
This was the third consecutive year of growth at SenzaGen AB.